Evidence map›Paper›PMID 38184638›Full record

ArticleEuropean journal of medical research2024

Optimizing cardiac amyloidosis assessment: utility of 1-h and 3-h

Aiganym Imakhanova, Reiko Ideguchi, Hiroaki Kawano, Koji Maemura, Takashi Kudo

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of medical research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Early timepointEJNMMI research · 2026
    Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Aiganym ImakhanovaDepartment of Radioisotope Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki University, Sakamoto 1-12-4, Nagasaki, 852-8523, Japan. imakhanova.a@mail.ru.ORCID http://orcid.org/0000-0001-6724-3224
Reiko IdeguchiDepartment of Radioisotope Medicine, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.
Hiroaki KawanoDepartment of Cardiovascular Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.
Koji MaemuraDepartment of Cardiovascular Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.
Takashi KudoDepartment of Radioisotope Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki University, Sakamoto 1-12-4, Nagasaki, 852-8523, Japan.
Nagasaki University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTransthyretin amyloid cardiomyopathy (ATTR-CM), characterized by the extracellular deposition of an insoluble amyloid protein in the heart, is one of the main causes of heart failure in elderly patients. In this study, our primary objective was to explore the diverse applications and temporal significance of 1-h and 3-h imaging using

methodsTwenty-seven patients at Nagasaki University Hospital who underwent

resultsAmong patients who underwent

conclusionOur study suggests that both 1-h and 3-h incubation times for

Indexed as

AmyloidosisHeart FailureAgedDiagnostic ImagingHeartHumansTechnetium Tc 99m PyrophosphateUnited StatesTechnetium Tc 99m Pyrophosphate99mTc-PYPATTR transthyretin cardiomyopathyIncubation timeNuclear imaging

Identifiers

PMID38184638
PMCPMC10770959
OpenAlexW4390638553

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.